The overview discusses fifty eight peptides in numerous clinical phases, indicating a robust pipeline of peptide therapies targeting PPIs.Clinical trials and preclinical studies are highlighted, displaying the efficacy of peptide vaccines in inducing an immune reaction, with the likely to improve survival rates for HCC clients.Peptides have weak me